Katz Seymour, Feldstein Richard
Dr. Katz serves as Clinical Professor of Medicine at the New York University School of Medicine in New York, New York, and as an Attending Gastroenterologist at North Shore University Hospital-Long Island Jewish Medical Center in Manhasset, New York.
Gastroenterol Hepatol (N Y). 2008 May;4(5):337-47.
As the baby-boomer generation enters the ranks of the elderly (defined as patients over 60 years of age), the increased burden of managing older inflammatory bowel disease (IBD) patients requires recognition of the impact of comorbid disease, polypharmacy, and surgical candidacy criteria. There is a surprisingly positive response to newer therapies and surgery, provided that a distinction is made between "fit elderly" and "frail elderly" patients. The former group should not be denied access to the newer biologics, clinical trials, or surgical alternatives on the basis of age alone. There is a need for clinicians caring for elderly IBD patients to be cognizant of the multiple and often disguised conditions contributing to disease management as well as the importance for careful allocation of health resources.
随着婴儿潮一代步入老年（定义为60岁以上的患者），管理老年炎症性肠病（IBD）患者的负担日益加重，这就需要认识到合并症、多种药物治疗以及手术候选标准的影响。只要区分“健康老年人”和“体弱老年人”患者，对新疗法和手术就会有出人意料的积极反应。不应仅基于年龄而拒绝前一组患者使用新型生物制剂、参加临床试验或选择手术替代方案。照顾老年IBD患者的临床医生需要认识到导致疾病管理的多种且常常隐匿的状况，以及谨慎分配医疗资源的重要性。
